Studies on biomarker development are important in the diagnosis or treatment of MDD from various perspectives, such as regarding the brain-derived neurotrophic factor, oxidative stress, and the hypothalamic–pituitary–adrenal axis [5,33,34]. The gene discussed is BDNF; the disease is major depressive disorder.